Home/Pipeline/Next-Generation Antimicrobials

Next-Generation Antimicrobials

Bacterial Infections / Antimicrobial Resistance

Discovery/Pre-clinicalActive

Key Facts

Indication
Bacterial Infections / Antimicrobial Resistance
Phase
Discovery/Pre-clinical
Status
Active
Company

About Syngulon

Syngulon is a Belgium-based synthetic biology company leveraging bacteriocins to create novel genetic tools for industrial biotechnology and healthcare. Operating as a 'Startup in the Labs,' it collaborates closely with academic partners across Europe and the US to develop its PARAGEN collection of natural and synthetic bacteriocins. The company's platform addresses critical industry challenges including the need for antibiotic-free biomanufacturing, robust contamination control, and new antimicrobials to combat rising resistance. Its approach is underpinned by a distinguished Scientific Advisory Board with deep expertise in microbiology and bacterial genetics.

View full company profile